116 related articles for article (PubMed ID: 9128847)
1. Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo.
Teixeira MM; Hellewell PG
Eur J Pharmacol; 1997 Apr; 323(2-3):255-60. PubMed ID: 9128847
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
4. Effects of agents which elevate cyclic AMP on guinea-pig eosinophil homotypic aggregation.
Teixeira MM; Rossi AG; Giembycz MA; Hellewell PG
Br J Pharmacol; 1996 Aug; 118(8):2099-106. PubMed ID: 8864548
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of a short-acting and a long-acting beta 2-adrenoceptor agonist in guinea pig skin.
Teixeira MM; Williams TJ; Hellewell PG
Eur J Pharmacol; 1995 Jan; 272(2-3):185-93. PubMed ID: 7713162
[TBL] [Abstract][Full Text] [Related]
6. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
Ezeamuzie CI; al-Hage M; Nwankwoala RN
Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.
Whelan CJ; Johnson M
Br J Pharmacol; 1992 Apr; 105(4):831-8. PubMed ID: 1354536
[TBL] [Abstract][Full Text] [Related]
8. The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
Tool AT; Mul FP; Knol EF; Verhoeven AJ; Roos D
Eur Respir J Suppl; 1996 Aug; 22():141s-145s. PubMed ID: 8871060
[TBL] [Abstract][Full Text] [Related]
9. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics.
Grutters JC; Brinkman L; Aslander MM; van den Bosch JM; Koenderman L; Lammers JW
Eur Respir J; 1999 Oct; 14(4):915-22. PubMed ID: 10573242
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of salbutamol and salmeterol on human eosinophil responses.
Ezeamuzie CI; al-Hage M
J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156
[TBL] [Abstract][Full Text] [Related]
12. Priming of eosinophil recruitment in vivo by LPS pretreatment.
Macari DM; Teixeira MM; Hellewell PG
J Immunol; 1996 Aug; 157(4):1684-92. PubMed ID: 8759756
[TBL] [Abstract][Full Text] [Related]
13. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
Yang Q; Battistini B; Pelletier S; Sirois P
Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
[TBL] [Abstract][Full Text] [Related]
15. Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils.
Rabe KF; Giembycz MA; Dent G; Perkins RS; Evans P; Barnes PJ
Eur J Pharmacol; 1993 Feb; 231(2):305-8. PubMed ID: 8095902
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro.
Alves AC; Pires AL; Cruz HN; Serra MF; Diaz BL; Cordeiro RS; Lagente V; Martins MA
Eur J Pharmacol; 1996 Sep; 312(1):89-96. PubMed ID: 8891583
[TBL] [Abstract][Full Text] [Related]
17. The effect of the selectin binding polysaccharide fucoidin on eosinophil recruitment in vivo.
Teixeira MM; Hellewell PG
Br J Pharmacol; 1997 Mar; 120(6):1059-66. PubMed ID: 9134218
[TBL] [Abstract][Full Text] [Related]
18. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
Spring J; Johnston SR; Seale J; Ind PW
Thorax; 1992 Nov; 47(11):948-51. PubMed ID: 1361250
[TBL] [Abstract][Full Text] [Related]
19. The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo.
Faccioli LH; Nourshargh S; Moqbel R; Williams FM; Sehmi R; Kay AB; Williams TJ
Immunology; 1991 Jun; 73(2):222-7. PubMed ID: 1649126
[TBL] [Abstract][Full Text] [Related]
20. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha).
Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA
Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
